|
OVID | Ovid Therapeutics Inc. |
|
|
OVID | Ovid Therapeutics Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.36 |
| Leverage | 29.99% |
| Market Cap | $ 123.0m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -36.2m |
| Margin | -325.95% |
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.